Correlation Between Elevation Oncology and AVROBIO

Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elevation Oncology and AVROBIO, you can compare the effects of market volatilities on Elevation Oncology and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and AVROBIO.

Diversification Opportunities for Elevation Oncology and AVROBIO

0.01

Correlation Coefficient

Elevation Oncology  AVROBIO

Significant diversification

The 3 months correlation between Elevation and AVROBIO is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and AVROBIO go up and down completely randomly.

Pair Corralation between Elevation Oncology and AVROBIO

Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the AVROBIO. In addition to that, Elevation Oncology is 2.06 times more volatile than AVROBIO. It trades about -0.06 of its total potential returns per unit of risk. AVROBIO is currently generating about 0.08 per unit of volatility. If you would invest  128.00  in AVROBIO on February 21, 2024 and sell it today you would earn a total of  10.00  from holding AVROBIO or generate 7.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Elevation Oncology  vs.  AVROBIO

Elevation Oncology

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Elevation Oncology showed solid returns over the last few months and may actually be approaching a breakup point.

AVROBIO

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in AVROBIO are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, AVROBIO may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Pair Trading with Elevation Oncology and AVROBIO

The main advantage of trading using opposite Elevation Oncology and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.

The idea behind Elevation Oncology and AVROBIO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.